Oscar Health, Inc. (NYSE:OSCR) Receives $21.56 Consensus PT from Analysts

Oscar Health, Inc. (NYSE:OSCR) has been assigned an average rating of “Hold” from the nine ratings firms that are covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a sell rating, two have issued a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $21.56.

OSCR has been the subject of several recent analyst reports. Jefferies Financial Group started coverage on shares of Oscar Health in a research report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price objective for the company. Bank of America cut Oscar Health from a “neutral” rating to an “underperform” rating and lowered their price objective for the stock from $21.00 to $13.50 in a research report on Wednesday, November 6th.

Oscar Health Trading Down 2.6 %

OSCR stock opened at $13.75 on Thursday. Oscar Health has a 1 year low of $13.05 and a 1 year high of $23.79. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The business’s 50-day moving average is $14.87 and its two-hundred day moving average is $16.80.

Oscar Health (NYSE:OSCR) last issued its earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. On average, equities research analysts anticipate that Oscar Health will post 0.91 EPS for the current fiscal year.

Insider Activity

In other news, CAO Victoria Baltrus sold 8,078 shares of Oscar Health stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $146,050.24. Following the transaction, the chief accounting officer now directly owns 146,036 shares of the company’s stock, valued at $2,640,330.88. The trade was a 5.24 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Mario Schlosser sold 6,516 shares of the stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $117,809.28. Following the sale, the insider now owns 81,962 shares of the company’s stock, valued at approximately $1,481,872.96. This represents a 7.36 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 103,610 shares of company stock valued at $1,847,519. Insiders own 25.11% of the company’s stock.

Hedge Funds Weigh In On Oscar Health

Several institutional investors have recently added to or reduced their stakes in OSCR. KBC Group NV lifted its position in Oscar Health by 56.1% during the 4th quarter. KBC Group NV now owns 7,107 shares of the company’s stock worth $96,000 after acquiring an additional 2,555 shares during the period. ORG Wealth Partners LLC acquired a new stake in shares of Oscar Health during the fourth quarter worth $100,000. Alberta Investment Management Corp purchased a new position in Oscar Health in the 4th quarter valued at $138,000. Virtu Financial LLC acquired a new position in Oscar Health in the 4th quarter valued at $140,000. Finally, Potentia Wealth purchased a new position in Oscar Health during the 4th quarter worth $141,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.